These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 803804)

  • 41. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK).
    Lepper AW; Atwell JL; Lehrbach PR; Schwartzkoff CL; Egerton JR; Tennent JM
    Vet Microbiol; 1995 Jul; 45(2-3):129-38. PubMed ID: 7571364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental production of infectious bovine keratoconjunctivitis: comparison of serological and immunological responses using pili fractions of Moraxella bovis.
    Pugh GW; Hughes DE
    Can J Comp Med; 1976 Jan; 40(1):60-6. PubMed ID: 1000379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotypic, phenotypic, and biological characteristics of Moraxella bovis.
    Schurig GG; Lightfoot DR; Troutt HF; Finkler BI
    Am J Vet Res; 1984 Jan; 45(1):35-9. PubMed ID: 6200014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intramuscular vaccination of young calves with a Salmonella Dublin metabolic-drift mutant provides superior protection to oral delivery.
    Mizuno T; McLennan M; Trott D
    Vet Res; 2008; 39(3):26. PubMed ID: 18275802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemagglutination, autoagglutination and pathogenicity of Moraxella bovis strains.
    Gil-Turnes C
    Can J Comp Med; 1983 Oct; 47(4):503-4. PubMed ID: 6667436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors related to the prevalence of infectious bovine keratoconjunctivitis.
    Webber JJ; Selby LA
    J Am Vet Med Assoc; 1981 Oct; 179(8):823-6. PubMed ID: 6281222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized and blinded field trial to assess the efficacy of an autogenous vaccine to prevent naturally occurring infectious bovine keratoconjunctivis (IBK) in beef calves.
    Funk L; O'Connor AM; Maroney M; Engelken T; Cooper VL; Kinyon J; Plummer P
    Vaccine; 2009 Jul; 27(34):4585-90. PubMed ID: 19531391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of macrophage migration-inhibition factor and protection from challenge exposure in calves vaccinated with Salmonella typhimurium.
    Habasha FG; Smith BP; Schwartz L; Ardans A; Reina-Guerra M
    Am J Vet Res; 1985 Jul; 46(7):1415-21. PubMed ID: 3896069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
    McConnel CS; Shum L; Gleeson BL; House JK
    Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship of feeding activity of face fly (Musca autumnalis DeGeer) to production of keratoconjunctivitis in calves.
    Brown JF; Adkins TR
    Am J Vet Res; 1972 Dec; 33(12):2551-5. PubMed ID: 4641212
    [No Abstract]   [Full Text] [Related]  

  • 51. A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis.
    Lepper AW; Elleman TC; Hoyne PA; Lehrbach PR; Atwell JL; Schwartzkoff CL; Egerton JR; Tennent JM
    Vet Microbiol; 1993 Jul; 36(1-2):175-83. PubMed ID: 7901935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of Bdellovibrio bacteriovorus 109J for the treatment of dairy calves with experimentally induced infectious bovine keratoconjunctivitis.
    Boileau MJ; Mani R; Breshears MA; Gilmour M; Taylor JD; Clinkenbeard KD
    Am J Vet Res; 2016 Sep; 77(9):1017-28. PubMed ID: 27580114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental bovine infectious keratoconjunctivitis caused by sunlamp irradiation and Moraxella bovis infection: resistance to re-exposure with homologous and heterologous Moraxella bovis.
    Hughes DE; Pugh GW; McDonald TJ
    Am J Vet Res; 1968 Apr; 29(4):829-33. PubMed ID: 5642356
    [No Abstract]   [Full Text] [Related]  

  • 54. Infectious bovine keratoconjunctivitis: bacteriologic, immunologic, and clinical responses of cattle to experimental exposure with Moraxella bovis.
    Weech GM; Renshaw HW
    Comp Immunol Microbiol Infect Dis; 1983; 6(1):81-94. PubMed ID: 6825419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunization of calves against salmonellosis.
    Smith BP; Habasha FG; Reina-Guierra M; Hardy AJ
    Am J Vet Res; 1980 Dec; 41(12):1947-51. PubMed ID: 7011126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of bovine carriers of Moraxella bovis by comparative cultural examinations of ocular and nasal secretions.
    Pugh GW; McDonald TJ
    Am J Vet Res; 1986 Nov; 47(11):2343-5. PubMed ID: 3789493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infectious bovine keratoconjunctivitis: an update.
    Miller RB; Fales WH
    Vet Clin North Am Large Anim Pract; 1984 Nov; 6(3):597-608. PubMed ID: 6393547
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of Moraxella bovis infections in calves using a long-acting oxytetracycline formulation.
    George LW; Smith JA
    J Vet Pharmacol Ther; 1985 Mar; 8(1):55-61. PubMed ID: 3989901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infectious bovine keratoconjunctivitis II. Antibodies in lacrimal secretions of cattle naturally or experimentally infected with Moraxella bovis.
    Nayar PS; Saunders JR
    Can J Comp Med; 1975 Jan; 39(1):32-40. PubMed ID: 803398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A five-year study of infectious bovine keratoconjunctivitis in a beef herd.
    Hughes DE; Pugh GW
    J Am Vet Med Assoc; 1970 Aug; 157(4):443-51. PubMed ID: 5465268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.